Activity of Cefiderocol Against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Endemic to Medical Centers in New York City

Therapeutic options for the treatment of infections owing to multidrug-resistant Gram-negative pathogens are often limited. Cefiderocol is a novel siderophore cephalosporin with activity against Gram-negative pathogens, including many multidrug-resistant strains. The activity of cefiderocol was exam...

Descripción completa

Detalles Bibliográficos
Autores principales: Iregui, Alejandro, Khan, Zeb, Landman, David, Quale, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2020
Materias:
Mechanisms
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368386/
https://www.ncbi.nlm.nih.gov/pubmed/32031915
http://dx.doi.org/10.1089/mdr.2019.0298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368386/
https://www.ncbi.nlm.nih.gov/pubmed/32031915
http://dx.doi.org/10.1089/mdr.2019.0298

Ejemplares similares